Publications 2025

Moosavi SH, Kryeziu K, Eilertsen IA, Nunes L, Hektoen M, Niederdorfer B, Reims HM, Syversveen T, Grut H, Dueland S, Line PD, Lothe RA, Sveen A (2025)
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer
Br J Surg, 112 (4)
DOI 10.1093/bjs/znaf072, PubMed 40235343

Publications 2024

Stern NM, Mikalsen LTG, Dueland S, Schulz A, Line PD, Stokke C, Grut H (2024)
The prognostic value of [¹⁸F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases
Clin Physiol Funct Imaging, 45 (1), e12908
DOI 10.1111/cpf.12908, PubMed 39358976

Publications 2023

Dueland S, Smedman TM, Syversveen T, Grut H, Hagness M, Line PD (2023)
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
JAMA Surg, 158 (9), e232932
DOI 10.1001/jamasurg.2023.2932, PubMed 37494056

Grut H, Line PD, Syversveen T, Dueland S (2023)
Metabolic Tumor Volume from ¹⁸F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases
Cancers (Basel), 16 (1)
DOI 10.3390/cancers16010019, PubMed 38201449

Publications 2022

Dueland S, Smedman TM, Grut H, Syversveen T, Jørgensen LH, Line PD (2022)
PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
Cancers (Basel), 14 (20)
DOI 10.3390/cancers14205042, PubMed 36291826

Grut H, Line PD, Syversveen T, Dueland S (2022)
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study
Ann Nucl Med, 36 (12), 1073-1081
DOI 10.1007/s12149-022-01796-8, PubMed 36241941

Publications 2021

Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl Int, 34 (11), 2205-2213
DOI 10.1111/tri.13995, PubMed 34792825

Dueland S, Syversveen T, Hagness M, Grut H, Line PD (2021)
Liver transplantation for advanced liver-only colorectal metastases
Br J Surg, 108 (12), 1402-1405
DOI 10.1093/bjs/znab196, PubMed 34117498

Eide IJZ, Grut H, Helland Å, Ekman S, Sørensen JB, Hansen KH, Grønberg BH, Cicenas S, Koivunen JP, Mellemgaard A, Brustugun OT (2021)
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
Acta Oncol, 60 (12), 1565-1571
DOI 10.1080/0284186X.2021.1973092, PubMed 34486915

Grut H, Line PD, Labori KJ, Schulz A, Dueland S (2021)
Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by ¹⁸F-FDG PET/CT
HPB (Oxford), 24 (7), 1055-1062
DOI 10.1016/j.hpb.2021.11.015, PubMed 34924292

Publications 2020

Dueland S, Syversveen T, Solheim JM, Solberg S, Grut H, Bjørnbeth BA, Hagness M, Line PD (2020)
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases
Ann Surg, 271 (2), 212-218
DOI 10.1097/SLA.0000000000003404, PubMed 31188200

Grut H, Stern NM, Dueland S, Labori KJ, Dormagen JB, Schulz A (2020)
Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases
Nucl Med Commun, 41 (9), 916-923
DOI 10.1097/MNM.0000000000001235, PubMed 32796480

Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
BJS Open, 4 (3), 467-477
DOI 10.1002/bjs5.50278, PubMed 32333527

Publications 2019

Dueland S, Grut H, Syversveen T, Hagness M, Line PD (2019)
Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis
Am J Transplant, 20 (2), 530-537
DOI 10.1111/ajt.15682, PubMed 31674105

Publications 2018

Grut H, Revheim ME, Line PD, Dueland S (2018)
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl Med Commun, 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843, PubMed 29683930

Publications 2017

Grut H, Dueland S, Line PD, Revheim ME (2017)
The prognostic value of ¹⁸F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur J Nucl Med Mol Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9, PubMed 29026950

Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br J Surg, 105 (3), 295-301
DOI 10.1002/bjs.10651, PubMed 29168565